| (USD) | Dec 2013 | Y/Y change |
|---|---|---|
| Revenue | 937.49K | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NYMXF returned -99.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -99.5% |
| 1 year | -99.7% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $9.23 (Oct 2011) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in NYMXF would be worth today ›No. Nymox Pharmaceutical Corporation has not paid a dividend in the past 12 months.
Nymox Pharmaceutical Corporation is part of the Healthcare sector.
Nymox Pharmaceutical Corporation has a market cap of 21.01K USD, based on the latest quote.